Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection

To evaluate the cost effectiveness of early treatment with direct-acting antiviral therapy in adolescent patients with chronic hepatitis C virus (HCV) infection compared with treatment deferral.

Source: The Journal of Pediatrics - February 6, 2019 Category: Pediatrics Authors: Joehl Nguyen, A. Sidney Barritt IV, Ravi Jhaveri Tags: Original Article Source Type: research